Mattonet, Katharina
Kabelege, Eliud
Mkinga, Getrude
Kolwey, Lena
Nkuba, Mabula
Masath, Faustine Bwire
Hermenau, Katharin
Schupp, Claudia
Steinert, Janina I
Hecker, Tobias
Funding for this research was provided by:
Universität Bielefeld
Article History
Received: 14 June 2024
Accepted: 26 August 2024
First Online: 31 August 2024
Declarations
:
: The study has obtained ethics clearance from the Ethics Review Boards of Bielefeld University (No. EUB 2024–071) in Germany, Technical University Munich (No. 2024–37-NM-BA) in Germany, the National Institute for Medical Research (No. NIMR/HQ/R.8c/Vol.I/2572) in Tanzania and the President’s Office, Regional Administration and Local Government Tanzania (PO-RALG; No. AB.307/323/01/137) in Tanzania. The clinical trial was registered at ClinicalTrials.gov [] under the identifier NCT06369025 [] on April 17, 2024.Students, whose parents have signed the informed consent form and who themselves provide oral informed consent, will be included in the study. The student’s oral informed consent is documented by the interviewer before the interview starts. Teachers and parents will be enrolled in the study if they give their written informed consent before baseline assessment. All informed consents consist of information about the objectives, procedures, risks and discomforts of the study, the voluntary nature of participation, the right to withdraw at any point during the interview, the right to refuse answers and to skip questions, assurance about the confidentiality of information and anonymity of identity, and the use of information for scientific purposes.
: Not applicable.
: The authors declare no competing interests.